Cargando…

Clinical factors related to severe enterocolitis after adjuvant CAPOX for colorectal cancer: a retrospective analysis

BACKGROUND: CAPOX regimen is a standard option in stage III adjuvant colon cancer. Gastrointestinal toxicity is well described with fluoropyrimidine regimens and can be life-threatening. Identification of risk factors associated with severe gastrointestinal toxicity may help clinicians when choosing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Felismino, Tiago Cordeiro, de Jesus, Victor Hugo Fonseca, de Mendonça Uchóa Junior, Bruno Cezar, Moura, Francisca Giselle Rocha, Riechelmann, Rachel P., Junior, Samuel Aguiar, de Mello, Celso Abdon Lopes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105333/ https://www.ncbi.nlm.nih.gov/pubmed/32256697 http://dx.doi.org/10.3332/ecancer.2020.1014

Ejemplares similares

The prognostic influence of tumour budding in Western patients with stage II colorectal cancer
por: Canguçu, Augusto Leite, et al.
Publicado: (2020)

Evaluation of prognostic factors in patients undergoing first-line chemotherapy for advanced biliary tract cancer: a retrospective analysis from a South American cancer centre
por: Felismino, Tiago Cordeiro, et al.
Publicado: (2022)

Is there a role for rechallenge and reintroduction of anti-EGFR plus chemotherapy in later lines of therapy for metastatic colorectal carcinoma? A retrospective analysis
por: Karani, Amanda, et al.
Publicado: (2020)

Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer
por: Degirmencioglu, Serkan, et al.
Publicado: (2019)

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
por: Snoeren, Nikol, et al.
Publicado: (2010)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
por: Hattori, Norifumi, et al.
Publicado: (2019)

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayeasian network meta-analysis
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2021)

Comparative efficacy of modified FOLFIRINOX, gemcitabine plus capecitabine and gemcitabine plus nab-paclitaxel as adjuvant treatment for resected pancreatic cancer: a Bayesian network meta-analysis
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2021)

Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report
por: Aomatsu, Naoki, et al.
Publicado: (2020)

Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
por: Nishimura, Junichi, et al.
Publicado: (2020)

Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study()()
por: Snoeren, Nikol, et al.
Publicado: (2017)

Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 after gastrectomy: a population-based cohort study using a nationwide claims database
por: Maeng, Chi Hoon, et al.
Publicado: (2023)

Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study
por: Osawa, Hiroshi, et al.
Publicado: (2015)

Necrotising enterocolitis
por: de Louvois, John
Publicado: (1986)

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX
por: Ramaswamy, Anant, et al.
Publicado: (2019)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)

Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer
por: Zhai, Zhiwei, et al.
Publicado: (2021)

Application of 3D Printing Technology in the Treatment of Hoffa's Fracture Nonunion
por: Mendonça, Celso Júnio Aguiar, et al.
Publicado: (2022)

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
por: Shah, Manish A., et al.
Publicado: (2023)

Characterization and Antiproliferative Activity of a Novel 2-Aminothiophene Derivative-β-Cyclodextrin Binary System
por: Ferreira, Elayne Barros, et al.
Publicado: (2018)

Idiopathic Lymphocele: A Possible Diagnosis for Infraclavicular Masses
por: Góes Junior, Adenauer Marinho de Oliveira, et al.
Publicado: (2012)

Stent Graft-in-Stent Graft as a Rescue Technique for Endovascular Treatment of Giant Extracranial Internal Carotid Aneurysm
por: Góes Junior, Adenauer Marinho de Oliveira, et al.
Publicado: (2016)

Enterocolitis
por: Cobb, O. W.
Publicado: (1906)

Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022)

Overview of Adult Sarcoma Burden and Clinical Pathways in Brazil
por: David, Bruna Bianca Lopes, et al.
Publicado: (2022)

Baroreflex sensitivity differs among same strain Wistar rats from the same laboratory
por: Valenti, Vitor E., et al.
Publicado: (2011)

Combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas: a retrospective single centre study
por: Ribeiro, Luiz Fernando, et al.
Publicado: (2022)

CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial
por: Liu, Fangqi, et al.
Publicado: (2016)

Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis
por: Seghesio, Eleonora, et al.
Publicado: (2021)

Endoscopic third ventriculostomy in the treatment of hydrocephalus: A 20-year retrospective analysis of 209 consecutive cases
por: Faquini, Igor Vilela, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
por: Mei, Wei-Jian, et al.
Publicado: (2023)

A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case report
por: Uji, Masahito, et al.
Publicado: (2016)

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
por: Overman, Michael J., et al.
Publicado: (2016)

Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial
por: Deng, Xiangbing, et al.
Publicado: (2021)

POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial
por: Su, Liyu, et al.
Publicado: (2022)

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis
por: Carvalho de Brito, Angelo Borsarelli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f7ja72i3001dbcsu9fm6sgl821